K562, or K-562 (ATCC® CCL-243TM)*, cells are a chronic myelogenous leukemia (CML) continuous cell line originally isolated from the pleural effusion of a 53-year old female. 1 The K562 cell line is highly undifferentiated and multipotential; it can be differentiated into early precursors of the monocytic, granulocytic, and erythrocytic series by different approaches.
Our K562 reporter cell lines can be used for in vitro or in vivo research. The luciferase (Fluc) and green fluorescence protein (GFP) reporters facilitate easy quantitation of cells for in vitro assays. Additionally, luciferase can be used for tracking tumor growth non-invasively in living animals through bioluminescence imaging.
Our K562-Fluc-TAA cell lines overexpress luciferase as well as oncology target antigens of interest for immunotherapy development, including human and cynomolgus macaque CD19, CD20, or BCMA. The absence of these markers on the parental K562-Fluc-Puro cell line facilitates target-specific studies using antigen positive and negative cell panels.
Our cells are generated by lentiviral vector transduction, ensuring high, constitutive expression of the transgenes. The lentiviral vectors used for these transductions are self-inactivating (SIN) vectors in which the viral enhancer and promoter has been deleted. This increases the biosafety of the lentiviral vectors by preventing mobilization of replication competent viruses.7
Don’t see what you need in our catalog? Our scientific team engineers cell lines, viral vectors, and assays and provides as much characterization data as you need to move forward with confidence.